Mini Self Tapping Locking Gold OD - 2.0 L - 8 - JEIL Medical

What is the Mini Self Tapping Locking Gold OD - 2.0 L - 8 from Jeil Medical?

The Mini Self Tapping Locking Gold OD - 2.0 L - 8 is a specialized fixation device designed by Jeil Medical for guided bone regeneration (GBR) procedures. This technical component, identified under reference 241.032008, belongs to a range of precision instruments intended for oral and implant surgery. Its design integrates a self-tapping function and a locking mechanism, optimizing stability during placement. The Gold OD designation highlights a specific finish unique to the quality standards of the manufacturer Jeil Medical Corp., ensuring consistent integration into demanding surgical protocols.

What are the clinical indications for this device?

This Jeil Medical device is primarily indicated in oral, maxillofacial, and implant surgery procedures requiring rigid fixation. It is used during guided bone regeneration (GBR) protocols to stabilize membranes or bone grafts. Its structure is adapted to the needs of dental surgeons and implantologists seeking a reliable solution to maintain the integrity of structures during the bone healing phase. The use of this product must be strictly reserved for qualified healthcare professionals trained in specific bone fixation techniques.

What are the technical characteristics of product 241.032008?

The Mini Self Tapping Locking Gold OD features precise technical specifications to meet the constraints of the oral environment. It displays a diameter or length of 2.0 L - 8 according to the nomenclature of the manufacturer Jeil Medical Corp. Its self-tapping property facilitates insertion into the bone without requiring complex prior tapping, while its locking function ensures superior mechanical hold. These characteristics allow for precise handling and a reduction in operating time during the critical phases of reconstructive surgery.

What are the contraindications for the use of this GBR equipment?

The use of this fixation device is contraindicated in patients with severe systemic pathologies affecting bone metabolism or healing. Local contraindications, such as an active infection at the surgical site or insufficient residual bone volume to ensure device stability, must be evaluated by the practitioner. It is imperative to consult the technical instructions provided by Jeil Medical to become aware of all precautions for use and clinical situations where the use of this equipment could be compromised.

What are the precautions for use for this non-resorbable device?

As a metallic fixation device for GBR, it is designed to maintain structural stability during the period necessary for osseointegration or regeneration. The practitioner must ensure adequate mucosal coverage to avoid any exposure of the material, which could lead to infectious complications. Removal protocols, if applicable, must follow the recommendations of the manufacturer Jeil Medical. Rigorous preoperative planning and regular postoperative follow-up are essential to guarantee the long-term clinical success of the treatment.

Who is the manufacturer and what standards are respected?

This product is manufactured by Jeil Medical Corp., a globally recognized player in the field of medical devices for bone surgery. Although detailed regulatory specifications such as the class or CE marking are not explicitly mentioned in the current technical data sheet, Jeil Medical is renowned for its rigorous manufacturing standards. For any precise information regarding certifications, compliance with the MDR regulation, or specific ISO standards, healthcare professionals are invited to systematically refer to the instructions for use and the official product labeling provided by Delynov.

State of the art

Guided bone regeneration (GBR) in implantology relies on membrane fixation quality.